Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2015-06-11. The firm has not generated any revenue.

Industry: Pharmaceutical Preparations Peers: REGENERX BIOPHARMACEUTICALS INC Bio Path Holdings Inc Onconetix Inc Cellectar Biosciences Inc Soligenix Inc Immix Biopharma Inc Inhibikase Therapeutics Inc THERALINK TECHNOLOGIES, INC.